Manchester Management Company, LLC

Manchester Management Company, LLC is a declared insider of Eupraxia Pharmaceuticals Inc., with filings sourced from SEDI. In total, 5 filings cover trades dated from 20 April 2022 to 10 May 2022.

The open-market record is one-sided, with 1 purchase worth €116k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 12 May 2022 with an open-market purchase (€116k) in Eupraxia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 13 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.